Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Virpax Pharmaceuticals, Inc. (VRPX)
Company Research
Source: Business Wire
BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced that Gerald W. Bruce, CEO, will present and host one-on-one meetings with investors at the Sidoti August Virtual Investor Conference, taking place on August 14-15, 2024. Joining him will be Vinay Shah, CFO.The presentation will begin at 2:30 PM (ET) on Wednesday, August 14th, and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_BEdsmtAvSLKxmX8cn7Uv7g. Virpax will also host virtual one-on-ones with investors on Wednesday and Thursday, August 14-15, 2024. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and you don't need to be a Sidoti client.About Sidoti Events, LLC (“Events”) and Sidoti & Company, LLC (“Sido
Show less
Read more
Impact Snapshot
Event Time:
VRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRPX alerts
High impacting Virpax Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
VRPX
News
- Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent DevelopmentsBusiness Wire
- Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15 [Yahoo! Finance]Yahoo! Finance
- Virpax Regains Compliance with Nasdaq Minimum Bid PriceBusiness Wire
- Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock.MarketBeat
- Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why? [Yahoo! Finance]Yahoo! Finance
VRPX
Sec Filings
- 9/17/24 - Form 8-K
- 8/13/24 - Form S-1/A
- 8/13/24 - Form 8-K
- VRPX's page on the SEC website